Skip to main content
Show full summary

Lord Mendelsohn to ask Her Majesty's Government how many courses of (1) antiviral, and (2) monoclonal, antibody treatments for COVID-19 are (a) currently held by NHS England, and (b) secured via new contracts.  HL6005

Question HL6005: tabled on 4 February 2022 and due for answer by 18 February 2022

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government how many courses of (1) antiviral, and (2) monoclonal, antibody treatments for COVID-19 are (a) currently held by NHS England, and (b) secured via new contracts.  HL6005
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.